Literature DB >> 20800519

Self-reported quality of life has no correlation with functional status in children and adolescents with spinal muscular atrophy.

Cristiane M de Oliveira1, Alexandra P de Q C Araújo.   

Abstract

BACKGROUND: Spinal muscular atrophy is one of the most common neuromuscular disorders in children. Associated with progressive muscular weakness, it may assume a chronic course. In chronic disorders it is of utmost importance to determine the quality of life level.
OBJECTIVE: To determine the level of quality of life in a cohort of SMA children and adolescents, and study its relation to motor ability.
METHODS: From the children and adolescents with confirmed SMA diagnosis (presence of deletion) followed at a University Hospital, we selected those that were 4 years or older. They were classified as SMA type II or III according to their best motor ability, evaluated according to the modified Hammersmith functional score, and undertook the AUQEI Portuguese version to determine quality of life. This is an Institutional Review Board approved study and consent was given by all those included.
RESULTS: Thirty-three children and adolescent with a mean age of 10.28 (± 4.71) took part of the study. The fourteen SMA type II had a mean Hammersmith score of 11 (± 9.50) and AUQEI of 55.85 (± 7.16), while the nineteen SMA type III scored 31.10 (± 12.30) and 52.94 (± 4.85). No significant difference was found when quality of life scores was compared among those groups.
CONCLUSION: On a self-reported scale it seems that regardless the functional status an SMA child and adolescent has a perception of good quality of life.
© 2010 European Paediatric Neurology Society. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20800519     DOI: 10.1016/j.ejpn.2010.07.003

Source DB:  PubMed          Journal:  Eur J Paediatr Neurol        ISSN: 1090-3798            Impact factor:   3.140


  9 in total

1.  Understanding Symptoms in RYR1-Related Myopathies: A Mixed-Methods Analysis Based on Participants' Experience.

Authors:  Carlos Capella-Peris; Mary M Cosgrove; Irene C Chrismer; M Sonia Razaqyar; Jeffrey S Elliott; Anna Kuo; Magalie Emile-Backer; Katherine G Meilleur
Journal:  Patient       Date:  2020-08       Impact factor: 3.883

Review 2.  Spinal muscular atrophy.

Authors:  Eugenio Mercuri; Charlotte J Sumner; Francesco Muntoni; Basil T Darras; Richard S Finkel
Journal:  Nat Rev Dis Primers       Date:  2022-08-04       Impact factor: 65.038

3.  Mixed methods analysis of Health-Related Quality of Life in ambulant individuals affected with RYR1-related myopathies pre-post-N-acetylcysteine therapy.

Authors:  Carlos Capella-Peris; Mary M Cosgrove; Irene C Chrismer; Magalie Emile-Backer; M Sonia Razaqyar; Jeffrey S Elliott; Anna Kuo; Paul G Wakim; Katherine G Meilleur
Journal:  Qual Life Res       Date:  2020-02-10       Impact factor: 4.147

Review 4.  Measuring quality of life in children with spinal muscular atrophy: a systematic literature review.

Authors:  Shalvaree Vaidya; Stefan Boes
Journal:  Qual Life Res       Date:  2018-07-24       Impact factor: 4.147

5.  Longitudinal changes in clinical outcome measures in COL6-related dystrophies and LAMA2-related dystrophies.

Authors:  Minal S Jain; Katherine Meilleur; Eunhee Kim; Gina Norato; Melissa Waite; Leslie Nelson; Michelle McGuire; Tina Duong; Katherine Keller; Donovan J Lott; Allan Glanzman; Kristy Rose; Marion Main; Courtney Fiorini; Irene Chrismer; Melody Linton; Monal Punjabi; Jeffrey Elliott; Fatoumata Tounkara; Ruhi Vasavada; Ranjani Logaraj; Jocelyn Winkert; Sandra Donkervoort; Meganne Leach; Jahannaz Dastgir; Linda Hynan; Carmel Nichols; Elizabeth Hartnett; Gilberto M Averion; James C Collins; Eunice S Kim; Angela Kokkinis; Alice Schindler; Kristen Zukosky; Robert Fee; Veronica Hinton; Payam Mohassel; Diana Bharucha-Goebel; Carole Vuillerot; Peter McGraw; Mark Barton; Joseph Fontana; Anne Rutkowski; A Reghan Foley; Carsten G Bönnemann
Journal:  Neurology       Date:  2019-10-25       Impact factor: 9.910

6.  Oral health, socio-economic and home environmental factors associated with general and oral-health related quality of life and convergent validity of two instruments.

Authors:  Janice S Paula; Marcelo C Meneghim; Antônio C Pereira; Fábio L Mialhe
Journal:  BMC Oral Health       Date:  2015-02-24       Impact factor: 2.757

7.  Quality of Life in SMA Patients Under Treatment With Nusinersen.

Authors:  Lucas Mix; Benedikt Winter; Claudia D Wurster; Sophia Platen; Simon Witzel; Zeljko Uzelac; Heiko Graf; Albert C Ludolph; Dorothée Lulé
Journal:  Front Neurol       Date:  2021-03-29       Impact factor: 4.003

8.  Disease burden of spinal muscular atrophy in Germany.

Authors:  Constanze Klug; Olivia Schreiber-Katz; Simone Thiele; Elisabeth Schorling; Janet Zowe; Peter Reilich; Maggie C Walter; Klaus H Nagels
Journal:  Orphanet J Rare Dis       Date:  2016-05-04       Impact factor: 4.123

9.  Understanding the experiences and needs of individuals with Spinal Muscular Atrophy and their parents: a qualitative study.

Authors:  Ying Qian; Sarah McGraw; Jeff Henne; Jill Jarecki; Kenneth Hobby; Wei-Shi Yeh
Journal:  BMC Neurol       Date:  2015-10-24       Impact factor: 2.474

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.